Characterisation of spinophilin immunoreactivity in postmortem human brain homogenates

Autor: Brocos-Mosquera, I., Nuñez del Moral, A., Morentin, B., Meana, J. Javier, Callado, Luis F., Erdozain, Amaia M.

Publikováno v: In Progress in Neuropsychopharmacology & Biological Psychiatry 2 February 2018 81:236-242

Differential brain ADRA2A and ADRA2C gene expression and epigenetic regulation in schizophrenia. Effect of antipsychotic drug treatment.

Autor: Brocos-Mosquera I; Department of Pharmacology, University of the Basque Country, UPV/EHU, Leioa, Bizkaia, Spain.; Centro de Investigación Biomédica en Red de Salud Mental (CIBERSAM), Leioa, Spain., Miranda-Azpiazu P; Department of Pharmacology, University of the Basque Country, UPV/EHU, Leioa, Bizkaia, Spain.; Centro de Investigación Biomédica en Red de Salud Mental (CIBERSAM), Leioa, Spain., Muguruza C; Department of Pharmacology, University of the Basque Country, UPV/EHU, Leioa, Bizkaia, Spain.; Centro de Investigación Biomédica en Red de Salud Mental (CIBERSAM), Leioa, Spain., Corzo-Monje V; Department of Pharmacology, University of the Basque Country, UPV/EHU, Leioa, Bizkaia, Spain., Morentin B; Section of Forensic Pathology, Basque Institute of Legal Medicine, Bilbao, Spain.; Biocruces Bizkaia Health Research Institute, Barakaldo, Bizkaia, Spain., Meana JJ; Department of Pharmacology, University of the Basque Country, UPV/EHU, Leioa, Bizkaia, Spain.; Centro de Investigación Biomédica en Red de Salud Mental (CIBERSAM), Leioa, Spain.; Biocruces Bizkaia Health Research Institute, Barakaldo, Bizkaia, Spain., Callado LF; Department of Pharmacology, University of the Basque Country, UPV/EHU, Leioa, Bizkaia, Spain.; Centro de Investigación Biomédica en Red de Salud Mental (CIBERSAM), Leioa, Spain.; Biocruces Bizkaia Health Research Institute, Barakaldo, Bizkaia, Spain., Rivero G; Department of Pharmacology, University of the Basque Country, UPV/EHU, Leioa, Bizkaia, Spain. guadalupe.rivero@ehu.eus.; Centro de Investigación Biomédica en Red de Salud Mental (CIBERSAM), Leioa, Spain. guadalupe.rivero@ehu.eus.; Biocruces Bizkaia Health Research Institute, Barakaldo, Bizkaia, Spain. guadalupe.rivero@ehu.eus.

Publikováno v: Translational psychiatry [Transl Psychiatry] 2021 Dec 20; Vol. 11 (1), pp. 643. Date of Electronic Publication: 2021 Dec 20.

Preclinical Evaluation of an Imidazole-Linked Heterocycle for Alzheimer's Disease.

Autor: Bagán A; Laboratory of Medicinal Chemistry (Associated Unit to CSIC), Department of Pharmacology, Toxicology and Medicinal Chemistry, Faculty of Pharmacy and Food Sciences, Institute of Biomedicine (IBUB), University of Barcelona, Av. Joan XXIII, 27-31, 08028 Barcelona, Spain., Rodriguez-Arévalo S; Laboratory of Medicinal Chemistry (Associated Unit to CSIC), Department of Pharmacology, Toxicology and Medicinal Chemistry, Faculty of Pharmacy and Food Sciences, Institute of Biomedicine (IBUB), University of Barcelona, Av. Joan XXIII, 27-31, 08028 Barcelona, Spain., Taboada-Jara T; Pharmacology Section, Toxicology and Medicinal Chemistry, Faculty of Pharmacy and Food Sciences, Institut de Neurociències, University of Barcelona, Av. Joan XXIII, 27-31, 08028 Barcelona, Spain., Griñán-Ferré C; Pharmacology Section, Toxicology and Medicinal Chemistry, Faculty of Pharmacy and Food Sciences, Institut de Neurociències, University of Barcelona, Av. Joan XXIII, 27-31, 08028 Barcelona, Spain.; Centro de Investigación Biomédica en Red Enfermedades Neurodegenerativas (CiberNed), National Institute of Health Carlos III, 28029 Madrid, Spain., Pallàs M; Pharmacology Section, Toxicology and Medicinal Chemistry, Faculty of Pharmacy and Food Sciences, Institut de Neurociències, University of Barcelona, Av. Joan XXIII, 27-31, 08028 Barcelona, Spain.; Centro de Investigación Biomédica en Red Enfermedades Neurodegenerativas (CiberNed), National Institute of Health Carlos III, 28029 Madrid, Spain., Brocos-Mosquera I; Department of Pharmacology, University of the Basque Country, UPV/EHU, 48940 Leioa, Spain.; Centro de Investigación Biomédica en Red de Salud Mental, CIBERSAM, 28029 Madrid, Spain., Callado LF; Department of Pharmacology, University of the Basque Country, UPV/EHU, 48940 Leioa, Spain.; Centro de Investigación Biomédica en Red de Salud Mental, CIBERSAM, 28029 Madrid, Spain.; Biocruces Bizkaia Health Research Institute, 48903 Barakaldo, Spain., Morales-García JA; Department of Cell Biology, School of Medicine, Complutense University (UCM), 28040 Madrid, Spain., Pérez B; Department of Pharmacology, Therapeutic and Toxicology, Autonomous University of Barcelona, 08193 Cerdanyola, Spain., Diaz C; Fundación MEDINA Centro de Excelencia en Investigación de Medicamentos Innovadores en Andalucía, Avda. del Conocimiento 34, 18016 Armilla, Spain., Fernández-Godino R; Fundación MEDINA Centro de Excelencia en Investigación de Medicamentos Innovadores en Andalucía, Avda. del Conocimiento 34, 18016 Armilla, Spain., Genilloud O; Fundación MEDINA Centro de Excelencia en Investigación de Medicamentos Innovadores en Andalucía, Avda. del Conocimiento 34, 18016 Armilla, Spain., Beljkas M; Department of Pharmaceutical Chemistry, Faculty of Pharmacy, University of Belgrade, Vojvode Stepe 450, 11221 Belgrade, Serbia., Oljacic S; Department of Pharmaceutical Chemistry, Faculty of Pharmacy, University of Belgrade, Vojvode Stepe 450, 11221 Belgrade, Serbia., Nikolic K; Department of Pharmaceutical Chemistry, Faculty of Pharmacy, University of Belgrade, Vojvode Stepe 450, 11221 Belgrade, Serbia., Escolano C; Laboratory of Medicinal Chemistry (Associated Unit to CSIC), Department of Pharmacology, Toxicology and Medicinal Chemistry, Faculty of Pharmacy and Food Sciences, Institute of Biomedicine (IBUB), University of Barcelona, Av. Joan XXIII, 27-31, 08028 Barcelona, Spain.

Publikováno v: Pharmaceutics [Pharmaceutics] 2023 Sep 25; Vol. 15 (10). Date of Electronic Publication: 2023 Sep 25.

α 2A - and α 2C -adrenoceptor expression and functionality in postmortem prefrontal cortex of schizophrenia subjects.

Autor: Brocos-Mosquera I; Department of Pharmacology, University of the Basque Country, UPV/EHU, Leioa, Bizkaia, Spain; Centro de Investigación Biomédica en Red de Salud Mental (CIBERSAM), Spain., Gabilondo AM; Department of Pharmacology, University of the Basque Country, UPV/EHU, Leioa, Bizkaia, Spain; Centro de Investigación Biomédica en Red de Salud Mental (CIBERSAM), Spain; Biocruces Bizkaia Health Research Institute, Barakaldo, Bizkaia, Spain., Diez-Alarcia R; Department of Pharmacology, University of the Basque Country, UPV/EHU, Leioa, Bizkaia, Spain; Centro de Investigación Biomédica en Red de Salud Mental (CIBERSAM), Spain; Biocruces Bizkaia Health Research Institute, Barakaldo, Bizkaia, Spain., Muguruza C; Department of Pharmacology, University of the Basque Country, UPV/EHU, Leioa, Bizkaia, Spain; Centro de Investigación Biomédica en Red de Salud Mental (CIBERSAM), Spain., Erdozain AM; Department of Pharmacology, University of the Basque Country, UPV/EHU, Leioa, Bizkaia, Spain; Centro de Investigación Biomédica en Red de Salud Mental (CIBERSAM), Spain., Meana JJ; Department of Pharmacology, University of the Basque Country, UPV/EHU, Leioa, Bizkaia, Spain; Centro de Investigación Biomédica en Red de Salud Mental (CIBERSAM), Spain; Biocruces Bizkaia Health Research Institute, Barakaldo, Bizkaia, Spain., Callado LF; Department of Pharmacology, University of the Basque Country, UPV/EHU, Leioa, Bizkaia, Spain; Centro de Investigación Biomédica en Red de Salud Mental (CIBERSAM), Spain; Biocruces Bizkaia Health Research Institute, Barakaldo, Bizkaia, Spain. Electronic address: LF.callado@ehu.eus.

Publikováno v: European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology [Eur Neuropsychopharmacol] 2021 Nov; Vol. 52, pp. 3-11. Date of Electronic Publication: 2021 Jun 20.

Benzofuranyl-2-imidazoles as imidazoline I 2 receptor ligands for Alzheimer's disease.

Autor: Rodriguez-Arévalo S; Laboratory of Medicinal Chemistry (Associated Unit to CSIC), Department of Pharmacology, Toxicology and Medicinal Chemistry, Faculty of Pharmacy and Food Sciences, Institute of Biomedicine (IBUB), University of Barcelona, Av. Joan XXIII, 27-31, E-08028, Barcelona, Spain., Bagán A; Laboratory of Medicinal Chemistry (Associated Unit to CSIC), Department of Pharmacology, Toxicology and Medicinal Chemistry, Faculty of Pharmacy and Food Sciences, Institute of Biomedicine (IBUB), University of Barcelona, Av. Joan XXIII, 27-31, E-08028, Barcelona, Spain., Griñán-Ferré C; Pharmacology Section, Toxicology and Medicinal Chemistry, Faculty of Pharmacy and Food Sciences, Institut de Neurociències, University of Barcelona, Av. Joan XXIII, 27-31, E-08028, Barcelona, Spain., Vasilopoulou F; Pharmacology Section, Toxicology and Medicinal Chemistry, Faculty of Pharmacy and Food Sciences, Institut de Neurociències, University of Barcelona, Av. Joan XXIII, 27-31, E-08028, Barcelona, Spain., Pallàs M; Pharmacology Section, Toxicology and Medicinal Chemistry, Faculty of Pharmacy and Food Sciences, Institut de Neurociències, University of Barcelona, Av. Joan XXIII, 27-31, E-08028, Barcelona, Spain., Brocos-Mosquera I; Department of Pharmacology, University of the Basque Country, UPV/EHU, E-48940, Leioa, Bizkaia, Spain; Centro de Investigación Biomédica en Red de Salud Mental, CIBERSAM, Spain., Callado LF; Department of Pharmacology, University of the Basque Country, UPV/EHU, E-48940, Leioa, Bizkaia, Spain; Centro de Investigación Biomédica en Red de Salud Mental, CIBERSAM, Spain., Loza MI; Innopharma Screening Platform, BioFarma Research Group, Centro de Investigación en Medicina Molecular y Enfermedades Crónica (CIMUS), Universidad de Santiago de Compostela, E-15782, Santiago de Compostela, Spain., Martínez AL; Innopharma Screening Platform, BioFarma Research Group, Centro de Investigación en Medicina Molecular y Enfermedades Crónica (CIMUS), Universidad de Santiago de Compostela, E-15782, Santiago de Compostela, Spain., Brea J; Innopharma Screening Platform, BioFarma Research Group, Centro de Investigación en Medicina Molecular y Enfermedades Crónica (CIMUS), Universidad de Santiago de Compostela, E-15782, Santiago de Compostela, Spain., Pérez B; Department of Pharmacology, Therapeutic and Toxicology, Autonomous University of Barcelona, E-08193, Cerdanyola, Spain., Molins E; Institut de Ciència de Materials de Barcelona (CSIC), Campus UAB, E-08193, Cerdanyola, Spain., De Jonghe S; KU Leuven, Department of Microbiology, Immunology and Transplantation, Rega Institute, Laboratory of Virology and Chemotherapy, Herestraat 49, 3000, Leuven, Belgium., Daelemans D; KU Leuven, Department of Microbiology, Immunology and Transplantation, Rega Institute, Laboratory of Virology and Chemotherapy, Herestraat 49, 3000, Leuven, Belgium., Radan M; Department of Pharmaceutical Chemistry, Faculty of Pharmacy, University of Belgrade, 11000, Belgrade, Serbia., Djikic T; Department of Pharmaceutical Chemistry, Faculty of Pharmacy, University of Belgrade, 11000, Belgrade, Serbia., Nikolic K; Department of Pharmaceutical Chemistry, Faculty of Pharmacy, University of Belgrade, 11000, Belgrade, Serbia., Hernández-Hernández E; IUNICS University of the Balearic Islands (UIB), Health Research Institute of the Balearic Islands (IdISBa), E-07122, Palma de Mallorca, Spain., García-Fuster MJ; IUNICS University of the Balearic Islands (UIB), Health Research Institute of the Balearic Islands (IdISBa), E-07122, Palma de Mallorca, Spain., García-Sevilla JA; IUNICS University of the Balearic Islands (UIB), Health Research Institute of the Balearic Islands (IdISBa), E-07122, Palma de Mallorca, Spain., Escolano C; Laboratory of Medicinal Chemistry (Associated Unit to CSIC), Department of Pharmacology, Toxicology and Medicinal Chemistry, Faculty of Pharmacy and Food Sciences, Institute of Biomedicine (IBUB), University of Barcelona, Av. Joan XXIII, 27-31, E-08028, Barcelona, Spain. Electronic address: cescolano@ub.edu.

Publikováno v: European journal of medicinal chemistry [Eur J Med Chem] 2021 Oct 15; Vol. 222, pp. 113540. Date of Electronic Publication: 2021 May 20.